A new schizophrenia drug revives the previously investigated drug xanomeline. Historically, physicians used xanomeline to treat Alzheimer’s disease until its removal from the market in 1998 because of gastrointestinal side effects. The investigation into its use for schizophrenia ceased for the same reason. However, an experimental drug, KarXT, combines xanomeline and trospium and takes a novel ...

There are many reasons to read. We read to progress in academics, to gain information, to communicate, and to learn. Reading has a long and illustrious history. Even with or current level of technology, reading is a required skill. However, my favorite reason for reading is escapism. With so much turmoil and uncertainty in the world, ...